Overview
Seiichiro Katagiri practices practicing medicine in Tokyo, Japan.
Katagiri is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Leukemia, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.
They are actively involved in clinical research, co-authoring 58 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Seiichiro Katagiri
Is Seiichiro Katagiri a top-rated expert for Chronic Myelogenous Leukemia (CML)?
MediFind is an objective health platform that identifies experts based on real-world data. Seiichiro Katagiri is classified as an Distinguished expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Seiichiro Katagiri participate in research or clinical trials?
Yes. Seiichiro Katagiri has published 58 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Seiichiro Katagiri's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Katagiri isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Advanced
- LeukemiaKatagiri isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Katagiri isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Katagiri isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute PainKatagiri isExperienced. Learn about Acute Pain.
- Anaplastic Large Cell LymphomaKatagiri isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Bone Marrow TransplantKatagiri isExperienced. Learn about Bone Marrow Transplant.
- CholedocholithiasisKatagiri isExperienced. Learn about Choledocholithiasis.
- Follicular LymphomaKatagiri isExperienced. Learn about Follicular Lymphoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myelodysplastic Syndrome (MDS)Katagiri isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaKatagiri isExperienced. Learn about Non-Hodgkin Lymphoma.
- Ovarian Hyperstimulation SyndromeKatagiri isExperienced. Learn about Ovarian Hyperstimulation Syndrome.
- PlasmacytomaKatagiri isExperienced. Learn about Plasmacytoma.
- RUNX1 Familial Platelet DisorderKatagiri isExperienced. Learn about RUNX1 Familial Platelet Disorder.